Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine applies a thermodynamic, computational discovery platform - ProMIS and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product portfolio includes PMN310 / Amyloid-beta, PMN267 / TDP-43, and PMN442 / Alpha-synuclein. The Company plans to investigate additional synucleinopathies, including Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Its wholly owned subsidiary is ProMIS Neurosciences (US) Inc.


NDAQ:PMN - Post by User

Post by Gbathaton Mar 24, 2021 4:47pm
147 Views
Post# 32869001

John W Henry is one of the new promises investors

John W Henry is one of the new promises investorsJohn William Henry II (born September 13, 1949)[2] is an American businessman and investor and the founder of John W. Henry & Company, an investment management firm. He is the principal owner of Liverpool Football Club, the Boston Red Sox, The Boston Globe, and co-owner of Roush Fenway Racing. In March 2006, Boston estimated Henry's net worth at $1.1 billion but noted that his company had recently experienced difficulties.[3] In November 2012, the company announced that it would stop managing clients' money by the end of the year, and Henry confirmed that total assets under the firm's management had fallen from $2.5 billion in 2006 to less than $100 million as of late 2012.[4] As of February 2021, Forbes estimated his net worth to be $2.8 billion.[5]

https://en.m.wikipedia.org/wiki/John_W._Henry
<< Previous
Bullboard Posts
Next >>